Deficiencies in NO production, eNOS expression, NOS coupling and/or NO-cGMP signaling in the kidney [8, 14, 41] and vasculature [42] have been reported as potential underlying mechanisms for fetal programming of hypertension. This evidence concerns the gene NOS2 and hypertensive disorder.